SEI Investments
VYGR icon

SEI Investments’s Voyager Therapeutics VYGR Stock Holding History

SEI Investments’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Buy
36,307
+7,370
+25% +$27.9K ﹤0.01% 3144
2026
Q1 		$112K Buy
+28,937
New +$114K ﹤0.01% 3076
2023
Q3 		– Sell
-33,788
Closed -$387K – 2701
2023
Q2 		$387K Buy
+33,788
New +$350K ﹤0.01% 2229

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments's VYGR Position: Q2 2026 in Review

SEI Investments increased its Voyager Therapeutics (VYGR) stake by 25% in Q2 2026, buying an estimated $27.9K and bringing the position to 36,307 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #3144.

SEI Investments first reported a position in VYGR in Q2 2023 and has held it in 3 quarters since. The position peaked at $387K in Q2 2023. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • SEI Investments held 36,307 shares of Voyager Therapeutics worth $127K as of Q2 2026.
  • SEI Investments bought 7,370 Voyager Therapeutics shares in Q2 2026, an estimated $27.9K.
  • Voyager Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3144 holding.
  • SEI Investments first reported a position in Voyager Therapeutics in Q2 2023 and has held it in 3 quarters since.
  • SEI Investments's Voyager Therapeutics position peaked at $387K in Q2 2023.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.